University of Rochester
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Rochester sits in the top decile of US sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count).
University of Rochester: 636 sponsored US clinical trials, 94 recruiting.
University of Rochester sponsors 636 registered US clinical trials on ClinicalTrials.gov, 94 of them currently recruiting, and 448 completed. 54 of these trials are in Phase 3-4 (later-stage) and 147 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 7 trials.
Top-decile sponsor footprint
University of Rochester ranks in the top decile of sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
448 of 506 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
636 total, page 8 of 13
Remote Access to Care, Everywhere, for Parkinson Disease
NCT02144220
Effects of Sustained Reading on the Ocular Surface
NCT02031172
A Phase II Study of Doxycycline in Relapsed NHL
NCT02086591
Bleach Bath Treatment of Adults With Atopic Dermatitis
NCT01996150
Realizing Opportunities for Self Empowerment
NCT02087956
Chinese Older Adults-Collaboration in Health (COACH)Study
NCT01938963
Optimizing Application And Support Of Immunization Information Systems (OASIS)
NCT02010372
Feasibility of an Exercise Intervention
NCT01984060
Novel Topical Therapies for the Treatment of Genital Pain
NCT02099006
Multicenter Observational Study of Myotonic Dystrophy Type 1
NCT02308657
Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer
NCT01837329
Adolescent to Adult-Oriented Health Care Transition Survey: Study of a Video-Based Educational Intervention
NCT02480660
Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations
NCT01988779
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
NCT01907659
Improving Palliative Care Through Teamwork
NCT01990742
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
NCT01978210
Effect of Music on Breastmilk
NCT01893047
Text Reminders to Immunize in a Managed Care Organization
NCT01806714
A Geriatric Assessment Intervention for Older Cancer Patients Receiving Chemotherapy
NCT01915056
Internet Self-Management for People With Intermittent Urinary Catheters
NCT02168465
Evaluate the Effectiveness of an Experimental Urethane Dimethacrylate Resin Based Dental Composite Material
NCT02018822
Exercise Intervention for Cancer Survivors and Caregivers
NCT01883635
Evaluating URMC's Massive Transfusion Protocol
NCT02083549
Impact of Respiratory Pathogens in Infants
NCT01789268
Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis
NCT01683799
Using EEG Operant Conditioning to Improve Trait Self-Control and Promote Healthy Behavior
NCT01801254
Ultrasound Measurement of Reactive Hyperemia in Critical Care
NCT01726595
Managing Sleep Symptoms and Modifying Mechanisms of Traumatic Stress
NCT01743339
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
NCT01603407
GRASSP: Gralise® for Spine Surgery Pain
NCT01764464
Strong Connections
NCT03308864
Alternative Approaches for Nausea Control
NCT01695993
HEALTHY (Health Education Adolescent Leadership Training to Help Youth) Leaders
NCT01708291
Web Assisted Tobacco Intervention With Community Colleges
NCT01692730
Violence and HIV Risk Among Women
NCT01695694
Long-term Efficacy Study of Sodium Channel Blocker in LQT3 Patients
NCT01648205
School-Based Telemedicine Enhanced Asthma Management
NCT01650844
Online Problem Solving Skills Training
NCT01711944
Glycerin Suppositories to Reduce Jaundice in Premature Infants
NCT01746511
Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)
NCT01698567
The Efficacy of Reminders to Complete HPV Series
NCT01731496
Improving Measurement Of Parents' Understanding Of Research Permission
NCT01704560
Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis
NCT01555957
Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease
NCT01648803
Restrictive Versus Liberal Transfusion Protocol in Infants Undergoing Cardiac Surgery
NCT01484886
Interactive Cholesterol Advisory Tool
NCT01890031
3D Ultrasound in Women With Vacuum or Forceps Deliveries
NCT01680731
Study of a Healthy Lifestyle Intervention for Deaf Adults Who Are Overweight or Obese
NCT01452269
Social Connections and Healthy Aging (The Senior Connection)
NCT01408654
Ranolazine Implantable Cardioverter-Defibrillator Trial
NCT01215253
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 66 |
| Phase 2 | 81 |
| Phase 3 | 20 |
| Phase 4 | 34 |
Therapeutic Areas
What is open in the University of Rochester pipeline
94 recruiting of 636 indexed (15% open); 448 completed (70%).
Phase mix: 54 late (III/IV) vs 147 early (I/II) (early-phase heavy).
Top condition: Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Rochester: open-pipeline peers nationwide
Peers matched on 636 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Rochester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 636 trials (± recruiting share)
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Southern California · 617 trials · 16% recruiting
- Baylor College of Medicine · 616 trials · 15% recruiting
- University of California, Davis · 657 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Loma Linda University · 15% recruiting · 237 trials
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Brown University · 15% recruiting · 231 trials
Related
What to do with this University of Rochester page
636 registered trials is a research-attention snapshot, not an endorsement of University of Rochester or any single study.
- 94 of University of Rochester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of Rochester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Rochester pipeline card: 636 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.